Artificial Nose Developer Collects 613 Million Odor Records for Chip Manufacturing
San Diego, Monday, 3 August 2026.
Ainos advanced its AI Nose platform by accumulating 613 million industrial smell data records to train its diagnostic model, despite reporting a second-quarter 2026 net loss of $4.6 million.
Ainos Inc. Reports Q2 2026 Results and Data Milestone
Ainos, Inc. (NASDAQ: AIMD) released its second quarter 2026 financial results on 3 August 2026, highlighting significant progress in the commercialization of its artificial intelligence nose technology [1]. The company reported that its AI Nose platform has accumulated approximately 613 million industrial smell data records since December 2025, primarily derived from semiconductor manufacturing environments [1][2]. This data accumulation supports the training of its Smell Language Model (SLM) and Smell AI Platform, marking a key milestone in the company’s development timeline [1].
Financial Performance and Operational Expenses
For the quarter ended 30 June 2026, Ainos recorded a net loss of $4.6 million, compared to a loss of $4.1 million in the same period of the previous year [2]. The change in net loss represents a 12.195 increase in losses year-over-year [2]. Revenue for the second quarter totaled $152, a decrease from the $4,663 reported in the second quarter of 2025 [2]. Total operating expenses for the quarter were $4.4 million, with research and development expenses accounting for $1.9 million of that total [2].
Commercial Deployments and Strategic Outlook
Commercially, Ainos is executing an initial $2.1 million commercial arrangement focused on backend semiconductor manufacturing environments [1]. The company continues pilot programs in front-end semiconductor environments and is expanding deployment activities in industrial and healthcare infrastructure settings [2]. Management aims to support broader revenue generation opportunities in the second half of 2026 through continued commercialization and strategic collaborations [1].
Cash Position and Future Capital Requirements
As of 30 June 2026, cash and cash equivalents stood at $1.4 million, an increase from $417,353 reported on 31 December 2025 [1][2]. The company reported total current assets of $2,188,538 against current liabilities that include $11,000,000 in convertible notes payable and $2,812,940 in loans payable [2]. Ainos stated its expectation of incurring net losses for the foreseeable future and emphasized reliance on raising additional capital to continue product development [2]. Forward-looking statements regarding revenue generation remain subject to market conditions and successful execution of commercial plans [alert! ‘Forward-looking statements are projections and not guarantees of future performance’][1].